ASCO Genitourinary Cancers Symposium
ASCO GU 2022: Phase II/III Clinical Results of IL-15RαFc Superagonist N-803 With BCG in BCG-Unresponsive NMIBC
By
ASCO Genitourinary Cancers Symposium
FEATURING
Sam Chang
By
ASCO Genitourinary Cancers Symposium
FEATURING
Sam Chang
Login to view comments.
Click here to Login